0

Empowering Swiss biotech

Industry platforms support all Swiss biotech companies on their journey

Swiss Biotech Ventures

Raise funding and find partners

Connect with investors and industry partners for financing, licensing, and research collaborations.

Learn more Swiss Biotech Orbit

Match talent with your opportunities

Access an international biotech talent pool and connect with qualified candidates confidentially.

Learn more Swiss Biotech Day

The power of international collaboration

Meet biotech leaders, investors, and partners at one of the world's premier biotechnology conferences.

Learn more Swiss Biotech Directory

Get discovered for new business

Showcase your company in the most comprehensive Swiss biotech company database.

Learn more
All platforms

Upcoming events

All events

Industry news

All news

Member spotlight of the day

Avrion Therapeutics AG

Avrion Therapeutics was founded in 2020 based on more than 10 years of research at EPFL. Avrion’s mission is to develop its first product AVR-001 as a treatment for amyotrophic lateral sclerosis (ALS) in addition to other programs of precision gene therapy solutions for neurodegenerative diseases.

View company profileVisit website
Employees in Switzerland
1–9
Founded
2020